Osteosarcoma in a pregnant patient with McCune-Albright syndrome

Bone

Volumn 45, Issue 3, 2009, Pages 603-608

  Kanazawa, Ippei ^a   Yamauchi, Mika ^a   Yano, Shozo ^a   Imanishi, Yasuo ^b   Kitazawa, Riko ^c   Nariai, Yoshiki ^a   Araki, Asuka ^a   Kobayashi, Keisuke ^b   Inaba, Masaaki ^b   Maruyama, Riruke ^a   Yamaguchi, Toru ^a   Sugimoto, Toshitsugu ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Acromegaly; McCune Albright syndrome; Osteosarcoma; Pregnant

Indexed keywords

ACROMEGALY; ADULT; ALBRIGHT SYNDROME; ARTICLE; BONE TURNOVER; CANCER RECURRENCE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GESTATIONAL AGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; MANDIBLE CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOPEDIC SURGERY; OSTEOSARCOMA; PREGNANT WOMAN; SKIN PIGMENTATION;

ACROMEGALY; ADULT; FEMALE; FIBROUS DYSPLASIA, POLYOSTOTIC; HUMANS; JAW NEOPLASMS; OSTEOSARCOMA; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC;

EID: 67949106443     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2009.05.018     Document Type: Article

References (39)

1. McCune D.J. Osteitis fibrosa cystica: the case of nine year old girl who exhibits precocious puberty, multiple pigmentation of the skin and hyperthyroidism. Am. J. Dis. Child. 52 (1936) 743-747
2. Albright F., Butler A.M., Hampton A.O., and Smith P. Syndrome characterized by osteitis fibrosa disseminate, areas of pigmentation and endocrine dysfunction, with precocious puberty in females. N. Engl. J. Med. 216 (1937) 726-746
3. Schwindinger W.F., Francomano C.A., and Levine M.A. Identification of a mutation in the gene encoding the α subunit of the stimulatory G protein of adenyl cyclase in the McCune-Albright syndrome. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 5152-5156
4. Weinstein L.S., Shenker A., Gejman P.V., Merino M.J., Freidman E., and Spiegel A.M. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N. Engl. J. Med. 325 (1991) 1688-1695
5. Taybi H., and Lachman R.S. Radiology of Syndromes, Metabolic Disorders, and Skeletal dysplasia. 4th ed (1996), Mosby, St Louis 183-184
6. Osada H., Sakamoto R., Seki K., and Sekiya S. Accelerated bone turnover in pregnant women with McCune-Albright syndrome. Gynecol. Obstet. Invest. 60 (2005) 102-107
7. Kaplan F.S., Fallon M.D., Boden S.D., Schmidt R., Senior M., and Haddad J.G. Estrogen receptors in bone in a patient with polyostotic fibrous dysplasia (McCune-Albright syndrome). N. Engl. J. Med. 319 (1988) 421-425
8. Schwartz D.T., and Alpert M. The malignant transformation of fibrous dysplasia. Am. J. Med. Sci. 247 (1964) 1-20
9. Bianco P., Riminucci M., Majolagbe A., Kuznetsov S.A., Collins M.T., Mankani M.H., et al. Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone. J. Bone Miner. Res. 15 (2000) 120-128
10. Imanishi Y., Tahara H., Palanisamy N., Spitalny S., Salusky I.B., Goodman W., et al. Clonal chromosomal defects in the molecular pathogenesis of refractory hyperparathyroidism of uremia. J. Am. Soc. Nephrol. 13 (2002) 1490-1498
11. Kitazawa S., Fukase M., Kitazawa R., Takenaka A., Gotoh A., Fujita T., et al. Immunohistologic evaluation of parathyroid hormone-related protein in human lung cancer and normal tissue with newly developed monoclonal antibody. Cancer 67 (1991) 984-989
12. Kobayashi K., Imanishi Y., Koshiyama H., Miyauchi A., Wakasa K., Kawata T., et al. Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia. Life Sci. 78 (2006) 2295-2301
13. Yabut S.M., Kenan S., Sossons H.A., and Lewis M.M. Malignant transformation of fibrous dysplasia. Clin. Orthop. 228 (1988) 281-289
14. Horvai A., and Unni K.K. Premalignant conditions of bone. J. Orthop. Sci. 11 (2006) 412-423
15. Ruggieri P., Sim F.H., Bond J.R., and Unni K.K. Malignancies in fibrous dysplasia. Cancer 73 (1994) 1411-1424
16. Rowe N.H., and Hungerford R.W. Osteosarcoma of the mandible. J. Oral Surg. 21 (1963) 42-49
17. Clark J.L., Unni K.K., Dahlin D.C., and Devine K.D. Osteosarcoma of the jaw. Cancer 51 (1983) 2311-2316
18. Beuerlein M.E., Schuller D.E., and De Young B.R. Maxillary malignant mesenchymoma and massive fibrous dysplasia. Arch. Otolaryngol. Head Neck Surg. 123 (1997) 106-109
19. Kaushik S., Smoker W.R.K., and Frable W.J. Malignant transformation of fibrous dysplasia into chondroblastic osteosarcoma. Skelet. Radiol. 31 (2002) 103-106
20. Farfel Z., Bourne H.R., and Iiri T. The expanding spectrum of G protein diseases. N. Engl. J. Med. 340 (1999) 1012-1020
21. Curran T., Miller A.D., Zokas L., and Verma I.M. Viral and cellular fos proteins: a comparative analysis. Cell 36 (1984) 259-268
22. Kovary K., and Bravo R. The jun and fos protein families are both required for cell cycle progression in fibroblasts. Mol. Cell. Biol. 11 (1991) 4466-4472
23. Wang Z.Q., Grigoriadis A.E., Mohle-Steinlein U., and Wagner E.F. A novel target cell for c-fos-induced oncogenesis: development of chondrogenic tumors in embryonic stem cell chimeras. EMBO J. 10 (1991) 2437-2450
24. Candeliere G.A., Glorieux F.H., Prud'homme J., and St-Arnaud R. Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia. N. Engl. J. Med. 332 (1995) 1546-1551
25. Parekh S.G., Donthineni-Rao R., Ricchetti E., and Lackman R.D. Fibrous dysplasia. J. Am. Acad. Orthop. Surg. 12 (2004) 305-313
26. Vosatka U., Hermanowski-Vosatka A., Metz R., and Ziff E.B. Dynamic interactions of c-fos protein in serum-stimulated 3T3 cell. J. Cell. Physiol. 138 (1989) 493-502
27. Wu J.X., Carpenter P.M., Gresens C., Keh R., Niman H., Morris J.W.S., et al. The proto-oncogene c-fos is over-expressed in the majority of human osteosarcomas. Oncogene 5 (1990) 989-1000
28. Bianco P., Kuznetsov S.A., Riminucci M., Fisher L.W., Spiegel A.M., and Robey P.G. Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gsα-mutated skeletal progenitor cells. J. Clin. Invest. 101 (1998) 1737-1744
29. Kovacs C.S. Calcium and bone metabolism in pregnancy and lactation. J. Clin. Endocrinol. Metab. 86 (2001) 2344-2348
30. Campanacci M., Bertoni F., and Capanna R. Malignant degeneration in fibrous dysplasia (presentation of 6 cases and review of the literature). Ital. J. Orthop. Traumatol. 5 (1979) 373-381
31. Yang R., Hoang B.H., Kubo T., Kawano H., Chou A., Sowers R., et al. Over-expression of parathyroid hormone type 1 receptor confers an aggressive phenotype in osteosarcoma. Int. J. Cancer 121 (2007) 943-954
32. Valin A., Guillen C., and Esbrit P. C-terminal parathyroid hormone-related protein (PTHrP) (107-139) stimulates intracellular Ca(2+) through a receptor different from the type 1 PTH/PTHrp receptor in osteoblastic osteosarcoma UMR 106 cells. Endocrinology 142 (2001) 2752-2759
33. Ardawi M.S., Nasrat H.A., and BA'Aqueel H.S. Calcium-regulating hormones and parathyroid hormone-related peptide in normal human pregnancy and postpartum: a longitudinal study. Eur. J. Endocrinol. 137 (1997) 402-409
34. Georgii-Hemming P., Wiklund H.J., Ljunggren O., and Nilsson K. Insulin-like growth factor I is a growth and survival factor in human multiple myeloma cell lines. Blood 88 (1996) 2250-2258
35. Ruggieri P., Sim F.H., Bond J.R., and Unni K.K. Malignancies in fibrous dysplasia. Cancer 73 (1994) 1411-1424
36. Lima G.A., Gomes E.M., Nunes R.C., Vieira Neto L., Sieiro A.P., Brabo E.P., et al. Osteosarcoma and acromegaly: a case report and review of the literature. J. Endocrinol. Invest. 29 (2006) 1006-1011
37. Kappel C.C., Velez-Yanguas M.C., Hirschfeld S., and Helman L.J. Human osteosarcoma cell lines are dependent on insulin-like growth factor I for in vitro growth. Cancer Res. 54 (1994) 2803-2807
38. Herzlieb N., Gallaher B.W., Berthold A., Hille R., and Kiess W. Insulin-like growth factor-I inhibits the progression of human U-2 OS osteosarcoma cells towards programmed cell death through interaction with the IGF-I receptor. Cell. Mol. Biol. 46 (2000) 71-77
39. MacEwen E.G., Pastor J., Kutzke J., Tsan R., Kurzman I.D., Thamm D.H., et al. IGF-I receptor contributes to the malignant phenotype in human and canine osteosarcoma. J. Cell. Biochem. 92 (2004) 77-91